New Hampshire Trust’s Bristol-Myers Squibb BMY Stock Holding History

New Hampshire Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572K	Hold	9,927	–	–	0.11%	114
2026 Q1	$602K	Hold	9,927	–	–	0.12%	106
2025 Q4	$535K	Sell	9,927 -30	-0.3%	-$1.44K	0.1%	110
2025 Q3	$449K	Hold	9,957	–	–	0.09%	128
2025 Q2	$461K	Sell	9,957 -168	-2%	-$8.25K	0.1%	118
2025 Q1	$618K	Buy	10,125 +30	+0.3%	+$1.75K	0.14%	91
2024 Q4	$571K	Sell	10,095 -188	-2%	-$10.5K	0.12%	104
2024 Q3	$532K	Hold	10,283	–	–	0.11%	113
2024 Q2	$427K	Sell	10,283 -1,210	-11%	-$54.1K	0.1%	125
2024 Q1	$623K	Sell	11,493 -305	-3%	-$15.5K	0.15%	98
2023 Q4	$605K	Sell	11,798 -195	-2%	-$10.2K	0.15%	103
2023 Q3	$696K	Sell	11,993 -77	-0.6%	-$4.72K	0.19%	88
2023 Q2	$772K	Sell	12,070 -639	-5%	-$42.8K	0.2%	89
2023 Q1	$881K	Sell	12,709 -283	-2%	-$20K	0.24%	83
2022 Q4	$935K	Buy	+12,992	New	+$980K	0.25%	86

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

New Hampshire Trust's BMY Position: Q2 2026 in Review

New Hampshire Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 9,927 shares worth $572K. The position accounts for 0.11% of the portfolio, ranked #114.

New Hampshire Trust first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $935K in Q4 2022. 918 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

New Hampshire Trust held 9,927 shares of Bristol-Myers Squibb worth $572K as of Q2 2026.
New Hampshire Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.11% of New Hampshire Trust's portfolio in Q2 2026, its #114 holding.
New Hampshire Trust first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
New Hampshire Trust's Bristol-Myers Squibb position peaked at $935K in Q4 2022.
918 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.